Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.
Sridhar R AllamAnn D KatariaMachaiah M MadhriraPhilip B AntiportaRanjit R NairJacfranz J GuiteauAshraf I ReyadPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2020)